BRAINSTORM CELL THERAPEUTICS
BCLI·10501E201·US·Common Stock·Healthcare - Biotechnology
BCLI institutional ownership changes in Q3 2025: 0 institutions opened or added positions, 14 trimmed or exited. BCLI (BRAINSTORM CELL THERAPEUTICS) is held by 2 institutional investors as of Q3 2025. Top institutional shareholders: OSAIC HOLDINGS, INC. ($1,351), Steward Partners Investment Advisory, LLC ($80). Net institutional sentiment: Bearish.
2
Holders
$1,431
Total Value
0% (14)
Consensus
0 buying - 14 selling
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold BCLI.
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer